tiprankstipranks
Indaptus Therapeutics (INDP)
NASDAQ:INDP
US Market

Indaptus Therapeutics (INDP) Financial Statements

Compare
477 Followers

Indaptus Therapeutics Financial Overview

Indaptus Therapeutics's market cap is currently $11.58M. The company's EPS TTM is $-1.72; its P/E ratio is ―; Indaptus Therapeutics is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.47. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit----$ -854.00K
Operating Income$ -16.38M$ -14.91M$ -7.73M$ -3.60M$ -34.95M
EBITDA$ -16.38M$ -14.91M$ -7.73M$ -3.60M$ -46.09M
Net Income$ -15.42M$ -13.73M$ -7.69M$ -3.57M$ -47.60M
Balance Sheet
Cash & Short-Term Investments$ 13.36M$ 26.43M$ 39.13M$ 1.64M$ 10.06M
Total Assets$ 14.92M$ 28.06M$ 40.58M$ 1.78M$ 21.28M
Total Debt$ 175.05K$ 80.49K$ 169.33K$ 0.00$ 1.34M
Net Debt$ -13.19M$ -9.55M$ -38.96M$ -1.64M$ -7.95M
Total Liabilities$ 2.85M$ 3.43M$ 4.68M$ 2.02M$ 9.74M
Stockholders' Equity$ 12.08M$ 24.63M$ 35.90M$ -237.70K$ 11.54M
Cash Flow
Free Cash Flow$ -13.41M$ -13.25M$ -11.29M$ -3.32M$ -29.97M
Operating Cash Flow$ -13.41M$ -13.08M$ -11.29M$ -3.32M$ -29.05M
Investing Cash Flow$ 17.14M$ -16.43M$ 447.75K$ 0.00$ -3.21M
Financing Cash Flow$ 0.00$ 0.00$ 48.34M$ 1.16M$ 2.37M
Currency in USD

Indaptus Therapeutics Earnings and Revenue History

Indaptus Therapeutics Debt to Assets

Indaptus Therapeutics Cash Flow

Indaptus Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis